Use of radionuclide imaging in acute coronary syndromes

Current Cardiology Reports

Volumn 5, Issue 1, 2003, Pages 25-31

  Abbott, Brian G ^a   Wackers, Frans J ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; FLUORODEOXYGLUCOSE F 18; LIPOCORTIN 5; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITROIMIDAZOLE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; SACCHARIC ACID; TECHNETIUM 99M; TETROFOSMIN TC 99M; THALLIUM 201;

ACUTE DISEASE; ACUTE HEART INFARCTION; CLINICAL OBSERVATION; CLINICAL TRIAL; COST CONTROL; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; EXERCISE TEST; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REPERFUSION; HEART SCINTISCANNING; HOSPITALIZATION; HUMAN; MEDICAL ASSESSMENT; NONHUMAN; PATIENT CARE; PREDICTION; REST; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX PAIN; CORONARY ARTERY DISEASE; HEART INFARCTION; PREDICTION AND FORECASTING; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SYNDROME;

ACUTE DISEASE; CORONARY DISEASE; HUMANS; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RADIONUCLIDE IMAGING; SENSITIVITY AND SPECIFICITY; SYNDROME;

EID: 1842865311     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-003-0034-z     Document Type: Review

References (36)

1. Duca MD, Giri S, Wu AH, et al.: Comparison of acute rest myocardial perfusion imaging and serum markers of myocardial injury in patients with chest pain syndromes. J Nucl Cardiol 1999, 6:570-576.
2. Hilton TC, Fulmer H, Abuan T, et al.: Ninety-day follow-up of patients in the emergency department with chest pain who undergo initial single-photon emission computed tomographic perfusion scintigraphy with technetium 99m-labeled sestamibi. J Nucl Cardiol 1996, 3:308-311.
3. Kontos MC, Jesse RL, Anderson FF, et al.: Comparison of myocardial perfusion imaging and cardiac troponin I in patients admitted to the emergency department with chest pain. Circulation 1999, 99:2073-2078.
4. Radensky PW, Hilton TC, Fulmer H, et al.: Potential cost effectiveness of initial myocardial perfusion imaging for assessment of emergency department patients with chest pain. Am J Cardiol 1997, 79:595-599.
5. Tatum JL, Jesse RL, Kontos MC, et al.: Comprehensive strategy for the evaluation and triage of the chest pain patient. Ann Emerg Med 1997, 29:116-125.
6. Weissman IA, Dickinson CZ, Dworkin HJ, et al.: Cost-effectiveness of myocardial perfusion imaging with SPECT in the emergency department evaluation of patients with unexplained chest pain. Radiology 1996, 199:353-357.
7. Udelson JE, Spiegler EJ: Emergency department perfusion imaging for suspected coronary artery disease: The ERASE chest pain trial. Maryland Med 2001, Suppl:90-94.
8. Stowers SA, Eisenstein EL, Wackers FJ, et al.: An economic analysis of an aggressive diagnostic strategy with single photom emission computed tomography myocardial perfusion imaging and early exercise stress testing in emergency department patients who present with chest pain but nondiagnostic electrocardiograms: results from a randomized trial. Ann Emerg Med 2000, 35:17-25.
9. Wackers FJ, Brown KA, Heller GV, et al.: American Society of Nuclear Cardiology position statement on radionuclide imaging in patients with suspected acute ischemic syndromes in the emergency department or chest pain center. J Nucl Cardiol 2002, 9:246-250.
10. Abbott BG, Abdel-Aziz I, Nagula S, et al.: Selective use of single-photon emission computed tomography myocardial perfusion imaging in a chest pain center. Am J Cardiol 2001, 87:1351-1355.
11. Miller TD, Christian TF, Hopfenspirger MR, et al.: Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation 1995, 92:334-341.
12. Miller TD, Hodge DO, Sutton JM, et al.: Usefulness of technetium-99m sestamibi infarct size in predicting posthospital mortality following acute myocardial infarction. Am J Cardiol 1998, 81:1491-1493.
13. Burns RJ, Gibbons RJ, Yi Q, et al.: The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol 2002, 39:30-36.
14. Sharir T, Germano G, Kang X, et al.: Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: Risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med 2001, 42:831-837.
15. Gibbons RJ, Miller TD, Christian TF: Infarct size measured by single photon emission computed tomographic imaging with (99m)Tc-sestamibi: a measure of the efficacy of therapy in acute myocardial infarction. Circulation 2000, 101:101-108.
16. Bruce CJ, Christian TF, Schaer GL, et al.: Determinants of infarct size after thrombolytic treatment in acute myocardial infarction. Am J Cardiol 1999, 83:1600-1605.
17. Watanabe J, Nakamura S, Sugiura T, et al.: Early identification of impaired myocardial reperfusion with serial assessment of ST segments after percutaneous transluminal coronary angioplasty during acute myocardial infarction. Am J Cardiol 2001, 88:956-959.
18. Castro PF, Corbalan R, Baeza R, et al.: Effect of primary coronary angioplasty on left ventricular function and myocardial perfusion as determined by Tc-99m sestamibi scintigraphy. Am J Cardiol 2001, 87:1181-1184.
19. Hirayama A, Kusuoka H, Adachi T, et al.: Comparison of time of reperfusion during anterior wall acute myocardial infarction to left ventricular volume one month and 20 months later. Am J Cardiol 2002, 89:1335-1340.
20. Brown KA, Heller GV, Landin RS, et al.: Early dipyridamole (99m)Tc-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events: Comparison with submaximal exercise imaging. Circulation 1999, 100:2060-2066.
21. Hofstra L, Liem IH, Dumont EA, et al.: Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 2000, 356:209-212.
22. Johnson LL, Schofield L, Mastrofrancesco P, et al.: Technetium-99m glucarate uptake in a swine model of limited flow plus increased demand. J Nucl Cardiol 2000, 7:590-598.
23. Khaw BA, Nakazawa A, O'Donnell SM, et al.: Avidity of technetium 99m glucarate for the necrotic myocardium: in vivo and in vitro assessment. J Nucl Cardiol 1997, 4:283-290.
24. Narula J, Petrov A, Pak KY, et al.: Very early noninvasive detection of acute experimental nonreperfused myocardial infarction with 99mTc-labeled glutarate. Circulation 1997, 95:1577-1584.
25. Mariani G, Villa G, Rossettin PF, et al.: Detection of acute myocardial infarction by 99mTc-labeled d-glucaric acid imaging in patients with acute chest pain. J Nucl Med 1999, 40:1832-1839.
26. Weinstein H, Reinhardt CP, Leppo JA: Direct detection of regional myocardial ischemia with technetium-99m nitroimidazole in rabbits. J Nucl Med 1998, 39:598-607.
27. Stone CK, Mulnix T, Nickles RJ, et al.: Myocardial kinetics of a putative hypoxic tissue marker, 99mTc-labeled nitroimidazole (BMS-181321), after regional ischemia and reperfusion. Circulation 1995, 92:1246-1253.
28. Fukuchi K, Kusuoka H, Watanabe Y, et al.: Ischemic and reperfused myocardium detected with technetium-99m-nitroimidazole. J Nucl Med 1996, 37:761-766.
29. Rumsey WL, Kuczynski B, Patel B, et al.: SPECT imaging of ischemic myocardium using a technetium-99m-nitroimidazole ligand. J Nucl Med 1995, 36:1445-1450.
30. Okada RD, Johnson III G, Nguyen KN, et al.: 99mTc-HL-91. Effects of low flow and hypoxia on a new ischemia-avid myocardial imaging agent. Circulation 1997, 95:1892-1899.
31. McNulty PH, Jagasia D, Cline G, et al.: Persistent changes in myocardial glucose metabolism in vivo during reperfusion of a limited duration coronary occlusion. Circulation 2000, 101:917-923.
32. Camici P, Aruaujo LI, Spinks T, et al.: Increased uptake of 18F-deoxyglucose in post-ischemic myocardium of patients with exercise-induced angina. Circulation 1986, 74:81-88.
33. Heller GV, Stowers SA, Hendel RC, et al.: Clinical value of acute rest technetium-99m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and nondiagnostic electrocardiograms. J Am Coll Cardiol 1998, 31:1011-1017.
34. Varetto T, Cantalupi D, Altieri A, et al.: Emergency room technetium-99m sestamibi imaging to rule our acute myocardial ischemic events in patients with nondiagnostic electrocardiograms. J Am Coll Cardiol 1993, 22:1804-1808.
35. Hilton TC, Thompson RC, Williams HJ, et al.: Technetium-99m sestamibi myocardial perfusion imaging in the emergency room evaluation of chest pain. J Am Coll Cardiol 1994, 23:1016-1022.
36. Bilodeau L, Theroux P, Gregoire J, et al.: Technetium-99m sestamibi tomography in patients with spontaneous chest pain: correlations with clinical, electrocardiographic, and angiographic findings. J Am Coll Cardiol 1991, 1:1684-1691.